NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it is entering the hemorrhoidopexy market for the first time with EEA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback